These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7364929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology.
    Koide Y, Inoue S, Murayama H, Kawai K, Yamashita K.
    Endocrinol Jpn; 1985 Oct; 32(5):615-24. PubMed ID: 3004927
    [Abstract] [Full Text] [Related]

  • 3. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [Abstract] [Full Text] [Related]

  • 4. The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
    Gross MD, Valk TW, Freitas JE, Swanson DP, Schteingart DE, Beierwaltes WH.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1062-6. PubMed ID: 6262361
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I, Lacroix A, Schürch W, Caron P, Antakly T, Stratakis CA.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [Abstract] [Full Text] [Related]

  • 8. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 9. Leptin inhibits cortisol and corticosterone secretion in pathologic human adrenocortical cells.
    Szücs N, Varga I, Jakab C, Patócs A, Gláz E, Tóth M, Kiss R, Rácz K.
    Pituitary; 2001 May; 4(1-2):71-7. PubMed ID: 11824511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I, Jakab C, Szücs N, Patócs A, Tóth M, Kiss R, Gláz E, Rácz K.
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [Abstract] [Full Text] [Related]

  • 12. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT, Simonson DC.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [Abstract] [Full Text] [Related]

  • 13. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 17. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P, Berselli ME, Tagliaferri M.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [Abstract] [Full Text] [Related]

  • 18. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y, Niinomi M, Takatsuki K, Oiso Y, Tomita A.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [Abstract] [Full Text] [Related]

  • 19. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [Abstract] [Full Text] [Related]

  • 20. Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia.
    Lamberts SW, Bons EG, Bruining HA.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1106-10. PubMed ID: 6327752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.